These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 10920697)
1. [Rapid increase of the use of PET in cancer investigation--but Sweden lags behind]. Wollmer P; Valind S; Landoni C; Fazio F Ugeskr Laeger; 2000 Jul; 162(27):3846-8. PubMed ID: 10920697 [TBL] [Abstract][Full Text] [Related]
2. [Rapid increase of the use of PET in cancer investigation--but Sweden lags behind]. Wollmer P; Valind S; Landoni C; Fazio F Lakartidningen; 2000 Apr; 97(16):1946-8. PubMed ID: 10826352 [TBL] [Abstract][Full Text] [Related]
3. New approach to clinical evaluation of cancer chemotherapy using positron emission tomography with 18FDG (2-deoxy-2-[18F]fluoro-D-glucose). Takahashi H; Yamaguchi K; Wakui A; Maeda S; Yang PK; Ito M; Matsuzawa T; Fukuda H; Ido T Sci Rep Res Inst Tohoku Univ Med; 1986 Dec; 33(1-4):38-43. PubMed ID: 3498212 [No Abstract] [Full Text] [Related]
4. [Potential use of positron-emission tomography in clinical oncology]. Fukuda H; Matsuzawa T; Tateno Y Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):860-5. PubMed ID: 3291774 [TBL] [Abstract][Full Text] [Related]
5. PET cancer evaluations with FDG. Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978 [No Abstract] [Full Text] [Related]
6. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography. Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564 [TBL] [Abstract][Full Text] [Related]
7. Use of positron emission tomography in oncology. Glaspy JA; Hawkins R; Hoh CK; Phelps ME Oncology (Williston Park); 1993 Jul; 7(7):41-6, 49-50; discussion 50-2, 55. PubMed ID: 8347460 [TBL] [Abstract][Full Text] [Related]
9. Positron-emitting radiopharmaceuticals: how safe are they? Silberstein EB Cancer Biother Radiopharm; 2001 Feb; 16(1):13-5. PubMed ID: 11279793 [No Abstract] [Full Text] [Related]
10. Development of oncology protocol using fluorine-18-FDG: one center's experience. Cronin V; Galantowicz P; Nabi HA J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608 [TBL] [Abstract][Full Text] [Related]
16. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis. Lewis PJ; Salama A J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664 [TBL] [Abstract][Full Text] [Related]
17. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma. Gritters LS; Francis IR; Zasadny KR; Wahl RL J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058 [TBL] [Abstract][Full Text] [Related]
18. [18FDG in the primary staging of lung tumors. Results with a gamma camera and a 511 keV collimator]. Trampert L; Holle LH; Berberich R; Alexander C; Ukena D; Ruth T; Sybrecht GW; Oberhausen E Nuklearmedizin; 1995 Jun; 34(3):79-86. PubMed ID: 7630746 [TBL] [Abstract][Full Text] [Related]
19. [PET evaluation of glucose metabolism in cancer]. Yasuda S; Fujii H; Takahashi W; Takagi S; Ide M; Shohtsu A Gan To Kagaku Ryoho; 1999 May; 26(6):756-61. PubMed ID: 10410143 [TBL] [Abstract][Full Text] [Related]
20. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]